` Comparison: CZO vs GIVN - Alpha Spread

CZO
vs
GIVN

Over the past 12 months, CZO has underperformed GIVN, delivering a return of 0% compared to the GIVN's 25% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CZO
GIVN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

CZO Intrinsic Value
HIDDEN
Show
GIVN Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Ceapro Inc
XTSX:CZO
5.99 CAD
Givaudan SA
SIX:GIVN
2 938 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CZO, GIVN

CZO
GIVN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Ceapro Inc
Revenue
Givaudan SA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
CZO, GIVN

CZO
GIVN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Ceapro Inc
XTSX:CZO
Givaudan SA
SIX:GIVN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

CZO
41.1%
GIVN
43.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Ceapro Inc
Givaudan SA

Operating Margin

CZO
-65.5%
GIVN
18.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Ceapro Inc
Givaudan SA

Net Margin

CZO
-48.9%
GIVN
14.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Ceapro Inc
Givaudan SA

FCF Margin

CZO
-47.8%
GIVN
16.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Ceapro Inc
Givaudan SA

ROE

CZO
-15.7%
GIVN
23.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Ceapro Inc
Givaudan SA

ROA

CZO
-13.6%
GIVN
8.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Ceapro Inc
Givaudan SA

ROIC

CZO
-23.2%
GIVN
11.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Ceapro Inc
Givaudan SA

ROCE

CZO
-19.3%
GIVN
14.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Ceapro Inc
Givaudan SA

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
CZO, GIVN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CZO, GIVN

Performance Gap Between CZO and GIVN
HIDDEN
Show

Performance By Year
CZO, GIVN

Loading
CZO
GIVN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CZO to other stocks
SHW
Sherwin-Williams Co
Cheaper
vs CZO
ECL
Ecolab Inc
Cheaper
vs CZO
4063
Shin-Etsu Chemical Co Ltd
Cheaper
vs CZO
600309
Wanhua Chemical Group Co Ltd
Cheaper
vs CZO
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett